1,344 results on '"Lagrou, Katrien"'
Search Results
2. Evaluation and implementation of optimized antimicrobial dosing strategies in obese and underweight patients
3. Review of the novel antifungal drug olorofim (F901318)
4. Risk factors for SARS-CoV-2 infection and severe COVID-19 in unvaccinated solid organ transplant recipients
5. Epidemiology and genetic diversity of human respiratory syncytial virus in Belgium between 2011 and 2019
6. Evolutionary origin and population diversity of a cryptic hybrid pathogen
7. Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre
8. Insights from Three Pan-European Multicentre Studies on Invasive Candida Infections and Outlook to ECMM Candida IV
9. Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study
10. Damping excessive viral-induced IFN-γ rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis
11. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients
12. Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study
13. Implementation of Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis in European Hospitals: A Survey from Belgium and a Literature Review of Test Performances in Different Patient Populations
14. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG
15. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study
16. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022
17. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study
18. The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid
19. Performances of disk diffusion method for determining triazole susceptibility of Aspergillus species: Systematic review
20. In vivo assessment of differences in fungal cell density in cerebral cryptococcomas of mice infected with Cryptococcus neoformans or Cryptococcus gattii
21. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
22. Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement.
23. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
24. Fetal Diagnosis and Therapy during the COVID-19 Pandemic: Guidance on Behalf of the International Fetal Medicine and Surgery Society
25. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
26. European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study
27. An observational cohort study of histological screening for BK polyomavirus nephropathy following viral replication in plasma
28. Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, Belgium
29. Molecular detection of SARS-COV-2 in exhaled breath at the point-of-need
30. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
31. Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort
32. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
33. Blood culture surveillance in a secondary care hospital in Benin: epidemiology of bloodstream infection pathogens and antimicrobial resistance
34. Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
35. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
36. Toxoplasmosis after allogeneic haematopoietic cell transplantation: experience using a PCR-guided pre-emptive approach
37. A role for extensive SARS‐CoV‐2 virological assessment of donor and recipient in lung transplantation.
38. Comparison of the Euroimmun Borrelia ‘antibody index’ with Virotech immunoblot-based detection of intrathecal Borrelia antibody production for the diagnosis of Lyme neuroborreliosis
39. Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.
40. First detection of triazole‐resistant aspergillus fumigatus harbouring the TR34/L98H Cyp51A mutation in Burkina Faso
41. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
42. Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis
43. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb
44. Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies
45. Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis
46. Trehalose as quantitative biomarker for in vivo diagnosis and treatment follow-up in cryptococcomas
47. Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus
48. Improving outcome of fungal diseases – Guiding experts and patients towards excellence
49. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
50. Epidemiology of Dermatophytes in Belgium: A 5 Years’ Survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.